mGluR3 Protein

📖 Wiki Page

protein1066 wordssynced 2026-04-02

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">mGluR3 Protein — Glutamate Metabotropic Receptor 3</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Metabotropic Glutamate Receptor 3</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GRM3</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q14832</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>98 kDa (879 aa)</td>
</tr>
<tr>
<td class="label">Structure</td>
<td>Class C GPCR: VFT, cysteine-rich, 7-TM domains</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain ([cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia), glial cells</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Presynaptic membrane, postsynaptic density</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">mGluR3 PAMs</td>
<td>Enhance receptor activity</td>
</tr>
<tr>
<td class="label">mGluR3 NAMs</td>
<td>Block receptor activity</td>
</tr>
<tr>
<td class="label">Gene Therapy</td>
<td>Restore expression</td>
</tr>
<tr>
<td class="label">Symptomatic Relief</td>
<td>Adjunct to antipsychotics</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a

...

mGluR3 Protein

Introduction

Mglur3 Protein — Glutamate Metabotropic Receptor 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

mGluR3 (Metabotropic Glutamate Receptor 3) is a G protein-coupled receptor that modulates both glutamatergic and GABAergic neurotransmission, playing important roles in neuroprotection, synaptic plasticity, and cognitive function[@nicoletti2011]. As a Group II metabotropic glutamate receptor (along with mGluR2), mGluR3 primarily couples to Gi/o proteins, inhibiting adenylate cyclase and reducing cAMP production.

Structure

mGluR3 shares the typical Class C GPCR architecture with distinct domains[@pin2003]:

Extracellular Domains

Venus Fly Trap (VFT) Domain: Large extracellular glutamate-binding domain (approximately 560 aa), forms homodimers
Cysteine-Rich Domain (CRD): Approximately 80 aa, connects VFT to transmembrane region, essential for signal transduction

Transmembrane Domains

7-TM Domain: Seven transmembrane helices that form the classic GPCR bundle
Intracellular Loops: Three intracellular loops involved in G protein coupling

Intracellular Domains

C-terminal Tail: Intracellular C-terminal tail (~100 aa) involved in signaling, trafficking, and protein interactions

The dimeric architecture of mGluR3 (and other Class C receptors) is essential for function - each protomer can bind glutamate, and the CRD transduces ligand binding to the transmembrane domain.

Normal Function

Neurotransmission Modulation[@schoepp2001]

mGluR3 serves crucial modulatory roles in synaptic transmission:

Presynaptic Autoreceptor Function: Located on presynaptic terminals, mGluR3 senses extracellular glutamate and inhibits further glutamate release
Presynaptic Heteroreceptor: Can also regulate release of other neurotransmitters including GABA
Postsynaptic Signaling: Modulates [NMDA](/entities/nmda-receptor) receptor function and dendritic excitability
Gi/o Coupling: Inhibits adenylate cyclase, reduces cAMP, activates GIRK channels

Neuroprotection

mGluR3 activation provides neuroprotective effects through multiple mechanisms:

Anti-apoptotic Signaling: Activates PI3K/Akt pathway, promoting neuronal survival
Excitotoxicity Reduction: Reduces excessive glutamate release, limiting excitotoxic damage
Glial Modulation: Regulates astrocyte and microglial function
Neurotrophic Factor Expression: Increases BDNF and GDNF expression

Synaptic Plasticity

Modulates both [LTP](/mechanisms/long-term-potentiation) and LTD in hippocampus and cortex
Involved in working memory and executive function
Regulates AMPA receptor trafficking

Cognitive Function

Critical for working memory processes
Role in executive function and decision-making
Modulates prefrontal cortical activity

Role in Neurodegenerative Diseases

Schizophrenia

mGluR3 is a significant therapeutic target for schizophrenia[@conn2014]:

Genetic Risk: GRM3 variants associated with schizophrenia risk
Expression Changes: Altered mGluR3 expression in prefrontal cortex of schizophrenic patients
Cognitive Deficits: mGluR3 dysfunction contributes to cognitive impairment
Therapeutic Approaches: mGluR3 positive allosteric modulators (PAMs) in development

Alzheimer's Disease

Expression Reduction: mGluR3 expression decreased in AD brains
Amyloid Interaction: [Aβ](/proteins/amyloid-beta) oligomers may affect mGluR3 signaling
Neuroprotective Potential: mGluR3 agonists could protect against [Aβ](/proteins/amyloid-beta) toxicity
Memory Function: Role in hippocampal synaptic plasticity affected in AD

Parkinson's Disease

Dopamine-Glutamate Interaction: mGluR3 modulates dopaminergic signaling
Levodopa-induced Dyskinesias: mGluR3 antagonists may reduce dyskinesias
Neuroprotection: Potential to protect dopaminergic [neurons](/entities/neurons)

Depression and Anxiety

mGluR3 Blockade: Shows antidepressant-like effects in animal models
Mood Regulation: Involved in mood and anxiety disorders
Fast-acting Antidepressants: mGluR2/3 antagonists (like ketamine metabolites) may contribute to rapid antidepressant effects

Amyotrophic Lateral Sclerosis

Motor Neuron Protection: mGluR3 activation may protect motor neurons
Glial Dysfunction: Altered mGluR3 signaling in ALS [astrocytes](/entities/astrocytes)
Therapeutic Potential: Being investigated as a neuroprotective target

Signaling Pathways

mGluR3 activates several downstream signaling cascades:

Gi/o-cAMP Pathway: Inhibits adenylate cyclase, reduces cAMP

PI3K/Akt Pathway: Pro-survival signaling, neuroprotection

MAPK/ERK Pathway: Regulates gene expression and plasticity

[NF-κB](/entities/nf-kb) Pathway: Modulates inflammatory responses

PLC Inhibition: Reduces IP₃ and DAG production

Therapeutic Targeting

Clinical Trials

mGluR2/3 modulators investigated for schizophrenia
mGluR3-targeted approaches for depression
Adjunctive therapy in AD

Animal Models

GRM3 Knockout Mice: Show altered glutamate signaling, cognitive deficits
Transgenic Overexpression: Protective in models of excitotoxicity
Conditional Deletion: Reveals region-specific functions

Biomarkers

Peripheral blood mononuclear cell GRM3 expression
CSF mGluR3 levels as potential biomarker
Genetic variants for patient stratification

Research Directions

Current research focuses on[@foster2017]:

Developing selective mGluR3 modulators for CNS disorders
Understanding mGluR2/3 heteromer pharmacology
Biomarker development for patient selection
Gene therapy approaches
Understanding role in glial cells

Key Publications

Conn PJ, et al. (2009). Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol. PMID: 18928405(https://pubmed.ncbi.nlm.nih.gov/18928405/)

Corti C, et al. (2007). Metabotropic glutamate receptors as therapeutic targets. Neuropharmacology. PMID: 17217965(https://pubmed.ncbi.nlm.nih.gov/17217965/)

Background

The study of Mglur3 Protein — Glutamate Metabotropic Receptor 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[UniProt: Q14832](https://www.uniprot.org/uniprot/Q14832)
[IUPHAR: mGluR3](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2975)
[PDB: 5CGC](https://www.rcsb.org/structure/5CGC)
[GTEx: GRM3 Expression](https://gtexportal.org/home/gene/GRM3)

References

[Nicoletti F, et al, Metabotropic glutamate receptors: from the structure to the pathophysiology of the central nervous system (2011)](https://pubmed.ncbi.nlm.nih.gov/21723945/)

[Pin JP, et al, Organization and functional expression of the family C G-protein-coupled glutamate receptors (2003)](https://pubmed.ncbi.nlm.nih.gov/12773627/)

[Schoepp DD, Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system (2001)](https://pubmed.ncbi.nlm.nih.gov/11561060/)

[Conn PJ, et al, Metabotropic glutamate receptors for neuropsychiatric treatment (2014)](https://pubmed.ncbi.nlm.nih.gov/23924867/)

[Foster DJ, et al, mGluR2/3 and mGluR5 as therapeutic targets for neuropsychiatric disorders (2017)](https://pubmed.ncbi.nlm.nih.gov/27543326/)

📖 View canonical wiki page →

mGluR3 Protein — Glutamate Metabotropic Receptor 3

mGluR3 Protein

mGluR3 Protein

Introduction

Overview

Structure

Extracellular Domains

Transmembrane Domains

Intracellular Domains

Normal Function

Neurotransmission Modulation[@schoepp2001]

Neuroprotection

Synaptic Plasticity

Cognitive Function

Role in Neurodegenerative Diseases

Schizophrenia

Alzheimer's Disease

Parkinson's Disease

Depression and Anxiety

Amyotrophic Lateral Sclerosis

Signaling Pathways

Therapeutic Targeting

Clinical Trials

Animal Models

Biomarkers

Research Directions

Key Publications

Background

See Also

External Links

References